Update on Dupilumab: HSE Drugs Group Supports Reimbursement

Potentially life-changing treatment one step closer for people struggling with moderate-to-severe atopic eczema¬† The HSE has advised that the HSE Drugs Group, the body which decides whether or not the Irish government will fund a new medicine through the public health system, supported reimbursement of dupilumab for a defined subgroup of the full licensed indication, […]

Updated frequent hand washing advice – BAD statement

Statement on frequent hand washing to reduce coronavirus risk for people with skin diseases affecting the hands   The British Association of Dermatologists (BAD) makes statements on best practice, teaching, training and research in dermatology which is often followed by dermatology departments and consultants in the Republic of Ireland. This statement was last updated by […]

A plan for waiting times? HSE publishes Scheduled Care Access Plan 2019

In an effort to tackle waiting times the HSE has published the Scheduled Care Access Plan 2019 which specifically identifies dermatology for extra resources. This move may help people with psoriasis, HS, atopic eczema, skin lesions and many other skin conditions access care more quickly. Under the plan the HSE intends to increase total number […]